Influence of estrogens on neurodegenerative processes

Medical Science Monitor

Volumn 9, Issue 10, 2003, Pages

  Członkowska, Anna ^a,b   Ciesielska, Agnieszka ^a,b   Joniec, Ilona ^b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Estrogen receptors; Gonadal sterolds; Neurodegeneration; Neuroprotectio

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NEUROTROPHIC FACTOR;

ANTIOXIDANT ACTIVITY; CELL SURVIVAL; DEGENERATIVE DISEASE; HORMONAL REGULATION; HUMAN; IMMUNOMODULATION; NERVE DEGENERATION; NEUROENDOCRINOLOGY; NEUROPROTECTION; REVIEW; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; APOLIPOPROTEINS E; BRAIN; CELL MEMBRANE; CELL SURVIVAL; ESTROGENS; FEMALE; HUMANS; MALE; NEURODEGENERATIVE DISEASES; NEURONS; RECEPTORS, ESTROGEN;

EID: 0142153146     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Grant K, Marsh P, Syniar G et al: Gender differences in rates of depression among undergraduates: measurement matters. Adolesc, 2002; 25: 613-7
2. Ozsvath KJ, Darling RE, Tabatabai L et al: Carotid endarterectomy in the elderly: does gender effect ontcome? Cardiovasc Surg, 2002; 10: 534-7
3. Samii A, Bickel U, Stroth U, Pardridge WM: Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am J Physiol, 1994; 267: E124-131
4. Pardridge WM, Yoshikawa T, Kang YS et al: Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. J Pharmacol Exp Ther, 1994; 268: 14-18
5. Carrcau S, Bourguiba S, Lambard S et al: Reproductive system: aromatase and estrogens. Mol Cell Endocrinol, 2002; 193: 137
6. Beyer C: Estrogen and the developing mammalian brain: Anat Embryol (Berl), 1999; 109: 379-390
7. McEwen BS, Alves SE; Estrogen actions in the central nervous system. Endoc Rev. 1999; 20: 279-307
8. Herbison AE: Multimodal influence of estrogen upon gonadotropin-releasing hormone neurons. Endocr Rev, 1998; 19: 302-330
9. McEwen BS, Parsons B: Gonadal steroid action on the brain: neurochemistry and neuropharmacology. Annu Rev Pharmacol Toxicol, 1982; 22: 555-598
10. Berman KF, Schmidt PJ, Rubinow DR et al: Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci USA, 1997; 94: 8836-8841
11. Tang MX, Jacobs D, Stern Y et al: Effect of oestrogen during menopause on risk and age at onset of Alzheimer disease. Lancet. 1996; 348: 429-432
12. Henderson AS, Easteal S, Jorm AF et al: Apolipoprotein E allele epsilon 4, dementia, and cognitive decline in a population sample. Lancet, 1995; 346: 1387-1390
13. Yaffe K, Sawaya G, Litberburg I et al: Estrogen therapy in post-menopausal women: effects on cognitive function and dementia. JAMA, 1998; 279: 688-695
14. Costa MM, Reus VI, Wolkowitz OM et al: Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol Psychiatry, 1999; 46: 182-188
15. Bedard P, Langelier P, Villeneuve A: Ocstrogens and the extrapyramidal system. Lancet, 1977; 2: 1367-1368
16. Dluzen D: Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res, 1997; 767: 340-344
17. Sindyk R: Estrogens and the pathophysiology of Parkinson's discase. Int J Neurosci, 1989; 45: 119-122
18. Saunders-Pullman R, Gordon-Elliott J, Parides M et al: The effect of estrogen replacement on early Parkinson's disease. Neurology, 1999; 52: 1417-1421
19. Dluzen DE, Disshon KA, Dermott JE: Estrogen as a modulator of stratial dopaminergic neurotoxicity. In Marwah J, Tielebeum H (eds.): Recent Advances in Neurodegenerative Disorders, pp. 149-192. Scottsdale, Arizona, USA: Prominent Press
20. Henderson VW, Paganini-Hill A, Miller BL. et al: Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology, 2000; 54: 295-301
21. Mulnard RA, Cotman CW, Kawas C et al: Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study. JAMA, 2000; 283: 1007-1016
22. Behl C, Widmann M, Trapp T et al: 17-beta estradiol protects neurons from oxidative strcss-induced cell death in vitro. Biochem Biophys Res Commun, 1995; 216: 473-482
23. Goodman Y, Bruce AI, Cheng B et al: Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem, 1996; 66: 1836-1844
24. Behl C, Skatella T, Lezoualc'h F et al: Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol, 1997; 51: 535-541
25. Gerlach M, Riederer P: Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm, 1996; 103: 987-1041
26. Dluzen DE, McDermott JL, Liu B: Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice. Neurotoxicol Teratol, 1996; 18: 603-606
27. Dluzen DE, McDermott JL, Liu B: Estrogen alters MPTP-induced neurotoxicity in female mice: effects on striatal dopamine concentrations and release. J Neurochem, 1996; 66: 658-666
28. Sawada H, Ibi M, Kihara T et al: Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res, 1998; 54: 707-719
29. Gold BG, Densmore V, Shou W et al: Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J Pharmacol Exp Ther, 1999; 289: 1202-1210
30. Azcotia I, Sierra A, Garcia-Segura LM: Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signaling. J Neurosci Res, 1999; 58: 815-822
31. Grandbois M, Morissette M, Callier S et al: Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice. Neuroreport, 2000; 11: 343-346
32. Mangelsdorf DJ, Thummel C, Beato M et al: The nuclear receptor superfamily: the second decade. Cell, 1995; 83: 835-839
33. Beato M, Chavez S, Truss M: Transcriptional regulation by steroid hormones. Steroids, 1996; 61: 240-251
34. Kuiper GG, Enmark E, Pelto-Huikko M et al: Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA, 1996; 93: 5925-5930
35. Li X, Schwartz PE, Rissman EF: Distribution of estrogen receptor-beta-like immunoreactivity in rat forebrain. Neuroendocrinology, 1997; 66: 63-67
36. DonCarlos LL, Greene GL, Morrell JI: Distribution of estrogen receptor-immunoreactive cells in the forebrain of the female guinea pig. J Comp Neurol, 1991; 305: 591-612
37. Küppers E, Beyer C: Expression of estrogen receptor alpha and beta mRNA in the developing and adult mouse striatum. Neurosci Letters, 1999; 276: 95-98
38. Taleghany N, Sarajari S, DonCarlos LL et al: Differential expression of estrogen receptor alpha and beta in rat dorsal root ganglion. J Neurosci Res, 1999; 57: 603-615
39. Koike S, Sakai M, Muramatsu M: Molecular cloning and characterization of rat estrogen receptor cDNA. Nucleic Acids Res, 1987; 15: 2499-2513
40. Chu S, Fuller PJ: Identification of a splice variant of the rat estrogen receptor beta gene. Mol Cell Endocrimol, 1997; 132: 195-199
41. Petersen DN, Tkalcevic GT, Koza-Taylor P et al: Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology, 1998; 139: 1082-1092
42. Hanstein B, Lilu H, Yaancisin MC et al: Functional analysis of a novel estrogen receptor-beta isoforms. Mol Endocrinol, 1999; 129-137
43. Beato M, Klug J: Steroid hormone receptors: an update. Hum Reprod Update, 2000; 6: 225-236
44. Pratt WB, Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endrocr Rev, 1997; 18: 306-360
45. Marin R, Guerra B, Alonso R: The amount of estrogen receptor-alpha increases after heat shock in a cholinergic cell line from the basal forebrain. Neuroscience, 2001; 107: 447-454
46. Cowley SM, Hoare S, Mosselman S et al: Estrogen receptor alpha and beta form heterodimers on DNA. J Biol Chem, 1997; 272: 19858-18862
47. Miller MM, Hyder SM, Assayag R et al: Estrogen modulates spontaneous alternation and the clolinergic phenotype in the basal forebrain. Neuroscience, 1999; 91: 1143-1153
48. Lee K, Richardson CD, Razik MA et al: Multiple potential regulatory elements in the 5′ flanking region of the human alpha 1a-adrenergic receptor. DNA Seq, 1998; 8: 271-276
49. Zhu YS, Pfaff DW: DNA binding of hypothalamic nuclear proteins on estrogen response element and preproencephalin promoter: modification by estrogen. Neuroendocrinology, 1995; 62: 454-466
50. Adan RA, Cox JJ, Beischlag TV et al: A composite hormone response element mediates the transactivation of the rat oxytocin gene by different classes of nuclear hormone receptors. Mol Endocrinol, 1993; 7: 47-57
51. Xu Y, Berelowitz M, Bruno JF: Characterization of the promoter region of the human somatostatin receptor subtype 2 gene and localization of sequences required for estrogen responsiveness. Mol Cell Endocrinol, 1998; 139: 71-77
52. Stone DJ, Song Y, Anderson CP et al: Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology, 1998; 139: 3202-3209
53. Solirabij F, Miranda RC, Toran-Allerand CD: Identification of putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc Natl Acad Sci USA, 1995; 92: 11110-11114
54. Teixeira C, Reed JC, Pratt MA: Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res, 1995; 55: 3902-3907
55. Donaghue C, Westley BR, May FE: Selective promoter usage of the human estrogen receptor-alpha gene and its regulation by estrogen. Mol Endocrinol, 1999; 13: 1934-1950
56. Tremblay A, Tremblay GB, Labrie F et al: Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell, 1999; 3: 513-519
57. Singer CA, Rogers KL, Dorsa DM: Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport, 1998; 9: 2565-2568
58. Gollapudi L, Oblinger MM: Stable transfection of PCI2 cells with estrogen receptor (ERalpha): protective effects of estrogen on cell survival after serum deprivation. J Neurosci Res, 1999; 56: 99-108
59. Garnier M, Di Lorenzo D, Albertini A et al: Identification of estrogen-responsive genes in neuroblastoma SK-ER3 cells. J Neurosci. 1997; 17: 4591-4599
60. Vegelo E, Pollio G, Pellicciari C et al: Estrogen and progesterone induction of survival of monoblastoid cells undergoing TNF-alpha-induced apoptosis. FASEB J, 1999; 13: 793-803
61. Singer CA, Figueroa-Masot XA, Batchelor RH et al: The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci, 1999; 19: 2455-2463
62. Stoltzner SE, Berchtold NC, Cotman CW et al: Estrogen regulates bcl-x expressinn in rat hippocampus. Neuroreport, 2001; 12: 2797-2800
63. Pike CJ: Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's discase. J Neurochem, 1999; 72: 1552-1568
64. Ghen DF, Schneider GE, Martinou JC et al: Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature, 1997; 385: 434-439
65. Holm K, Isacson O: Factors intrinsic to the neuron can induce and maintain it ability to promote axonal outgrowth: a role for BCL.2? Trends Neurosci, 1999; 22: 269-273
66. Bogdanov MB, Ferrante RJ, Mueller G et al: Oxidative stress is attenuated in mice overexpressing BCL-2. Neurosci Lett, 1999; 262: 33-36
67. Lorenzo A, Diaz H, Carrer H et al: Amygdala neurons in vitro: neurite growth and effects of estradiol. J Neurosci Res, 1992; 33: 418-435
68. Singer CA, Pang PA, Dobie DJ et al: Estrogen increases GAP-43 (neuromodulin) mRNA in the preoptic area of aged rats. Neurobiol Aging, 1996; 17: 661-663
69. Kelly MJ, Levin ER: Rapid action of plasma membrane estrogen receptors. Trends Endocrinol Metabolism, 2001; 12: 152-156
70. Bruce S, McEwen S, Alves E: Estrogen action in the central nervous system, Endocrine Reviews, 1999; 20: 279-307
71. Behl C, Holsboer F: The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci, 1999; 20: 441-444
72. Pietras R, Szego CM: Specific binding sites for oestrogen at the outer surfaces of isolated eudometrial cells. Nature, 1977; 265: 69-72
73. Pietras RJ, Szego CM: Partial purification and characterization of oestrogen receptors in subfractions of hepatocyte plasma membranes. Biochem J, 1980; 191: 743-760
74. Green PS, Bishop J, Simpkins JW: 17α-estradiol exerts neoroprotective effects on SK-N-SH cells. J Neurosci, 1997; 17: 511-515
75. Grenn PS, Gridley KE, Simpkins JW: Nuclear estrogen receptor-independent neuroprotection by estratienes: a novel interaction with glutathione. Neuroscience, 1998; 84: 7-10
76. Mermelstein PG, Becker JB, Surmeier DJ: Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci Res, 1996; 16: 595-604
77. Kelly MJ, Wagner EJ: Estrogen modulation of G-protein-coupled receptor. TEM, 1999; 10: 369-374
78. Singh M, Setalo G, Guan X et al: Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci, 1999; 19: 1179-1188
79. Watters JJ, Campbell JS, Cunningham MJ et al: Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology, 1997; 138: 4030-4053
80. Stefano GB, Prevot V, Beauvillain J-C et al: Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation, 2000; 101: 1594-1597
81. Choi DW: Excitotoxic cell death. J Neurobiol, 1992; 23: 1261-1276
82. Weaver GE, Park-Chung M, Gibbs TT et al: 17β-Estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res, 1997; 761: 338-341
83. +-ATPase activity, glucose transport and glutmate transport induced by amyloid β-peptide and iron. J Neurosci Res, 1997; 50: 522-530
84. Mooradian AD: Antioxidant: properties of steroids. J Steroid Biochem Mol Biol, 1993; 45: 509-511
85. Bonnefont AB, Munoz FJ, Inestrosa N: Estrogen protects neuronal cells from the cytotoxicity induced by acetylcholinesterase-amyloid complexes. FEBS Lett, 1998; 441: 220-224
86. Green PS, Gordon K, Simpkins JW: Phenolic A ring requirement fbr the neuroprotective effects of steroids. J Steroid Biochem Mol Biol, 1997: 63: 229-235
87. Gridley KE, Green PS, Simpkins J W: A novel, synergistic interaction between 17 beta estradiol and glutathione in the protection of neurons against β-amyloid 25-35-induced toxicity in vilro. Mol Pharmacol, 1998; 54: 874-80
88. Kirs SJ, Morito C. Horynkiewicz O: Gluthatione peroxidase activity in Parkinson's disease brain. Neurosci Lett, 1985; 58: 343-46
89. Toran-Allerand CD, Miranda RC, Bentham WD et. al: Estrogen receptors co-localize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA, 1992; 89: 4668-4672
90. Toran-Allerand CD: Mechanisms of estrogen action during neuronal development: mediation by mediation by interactions with the neurotrophins and their receptors? J Steroid Biochem Mol Biol, 1996; 56: 169-178
91. Singh M, Meyer EM, Simpkins JW: The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague Dawley rats. Endocrinology, 1995; 136: 2320-2324
92. Gibbs RB: Treatment with estrogen and progesterone affects relatire levels of brain-derived neurotrophic factor mRNA and protein in different regions of the adult rat brain. Brain Research, 1999; 844: 20-27
93. McMillan PJ, Singer CA, Dorsa DM: The effect of ovariectomy and estradiol replacemeut on trkA and choline acetyltransferase mRNA expression in the basal forebrain of the adult female Sprague Dawley rat, J Neurosci, 16 1860-1863
94. Gibbs RB: Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Expl Neurol, 1998; 151: 289-302
95. Miranda R, Sohrabij F, Singh M et al: Nerve growth factor (NGF) regulation of estrogen receptors in explant cultures of the developing forebrain. J Neurobiol, 1996; 31: 77-87
96. Agrati P, Garnier M, Patrone C et al: SK-ER3 neuroblastoma cells as a model for the study of estrogen influence on neural cells. Brain Res Bull, 1997; 44: 519-523
97. Ojeda SR, Ma YJ, Rage F: The transforming growth factor alpha gene family is involved in the neuroendocrine control of mammalian puberty. Mol Psychiat, 1997; 2: 355-358
98. Duenas M, Luquin S, Chowen JA et al: Gonadal hormone regulation of insulin growth factor-I-like immunoreactivity in hypothalamic astroglia of developing and adult rat. Neuroendocriology, 1994; 59: 528-538
99. Duenas M, Torres-Aleman I, Naftolin F et al: Interaction of insulin-like growth factor-I and estradiol signaling pathways on hypothalamic neuronal differentiation. Neuroscience, 1996; 74: 531-539
100. Cardona-Gomez GP, Doncarlos L, Garcia-Segura LM: Insulin-like growth factor I receptors and estrogen receptors co-localize in female rat brain. Neurosience 2000; 99: 751-760
101. Toran-Allerand CD, Ellis L, Pfenninger KH: Estrogen and insulin synergism in neurite growth enhancement in vitro: mediation of steroid effects by interactions with growth factor? Brain Res, 1988; 469: 87-100
102. Fernandes-Galaz MC, Morschl E, Chowen JA et al: Role of astroglia and insulin-like growth factor I in gonadal hormone-dependent synaptic plasticity. Brain Res Bull, 1997; 44: 525-531
103. Dore S, Kar S, Quirion R: Rediscovering an old friend, IGF-I potential use in the treatment of neurodegenerative diseases. Trends Neurosci, 1997; 20: 326-331
104. Fernandez AM, Gonzales de la Vega AG, Tores-Aleman 1: Neuroprotective actions of peripherally administered insulin-like growth factor I in the injured olivo-cerebellar pathway. Eur J Neurosci, 1999; 11: 2019-2030
105. Carro E, Trejo JL, Busiguina S et al: Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci, 2001; 21: 5678-5684
106. Azcoitia I, Sierra A, Garcia-Seguri I, M: Localization of estrogen receptor beta-immunoreactivity in astrocytcs of the aduh rat brain. Glia, 1999; 26: 260-267
107. Carcia-Segura I.M, Rodriguez JR, Torres-Aleman I: Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: an electron microscopic study. J Neurocytol, 1997; 26: 479-490
108. Welsh-Bohmer KA, Gearing M, Saunders AM et al: Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease. Ann Neurol, 1997; 42: 319-325
109. Strittmatter WJ, Roses AD: Apolipoprotein E and Alzheimer's disease. Annu Rev Neurosci, 1996; 19: 53-77
110. Bertrand P, Poirier J, Oda T et al: Association of apolipoprotein E genotype with brain levels of apolipoprotein E and apolipoprotein J (clusterin) in Alzheimer's disease. Brain Res Mol Brain Res, 1995; 33: 174-178
111. Pitas RE, Boyles JK, Lee SH et al: Lipoproteins and their receptors in the central nervous system. Characterization of the lipoproteins nervous system. in cerebrospinal fluid and identification of apolipoprotein B, E (LDL) receptors in the brain. J Biol Chem, 1987; 262: 14352-14360
112. Harr SD, Unit L, Hollister R et al: Brain expression of apolipoprotein E, J and A-I in Alzheimer disease. J Neurochem, 1996; 66: 2429-2435
113. Fagan AM, Bu G, Sun Y et al: Apolipoprotein E containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein. J Biol Chem, 1996; 23: 191-201
114. Stone DJ, Rozovsky I, Morgan TE et al: Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer disease. J Neurosci, 1998; 18: 3180-3185
115. Laskowitz DT, Sheng H, Bart RD et al: Apolipoprotein E-delicient mice have increased susceptibility to focal cerebral ischemia. J Cereb Blood Flow Metab, 1997; 17: 753-758
116. Keller JN, Lauderback ChM, Butterfield DA et al: Amyloid beta-peptide effects on synaptosomes from apolipoprotein E-deficient mice. J Neurochem, 2000; 74: 1579-1586
117. Chen J, Lomnitski L, Michaelson DM et al: Motor and cognitive delicits in apolipoprotein E-deficient mice after closed head injury. Neuroscience, 1997; 80: 1255-1262
118. LeBlanck AC, Poduslo JF: Regulation of apolipoprotein E gene expression after injury of the rat sciatic nerve. J Neurosci Res, 1990; 25: 162-171
119. Poirier J: Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci, 1994; 17: 525-553
120. Teter B, Harris-White ME, Frautschy SA et al: Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures. Neuroscience, 1999; 91: 1009-1016
121. Brandi ML, Becherini L, Gennari L et al: Association of the ER alpha gene polymorphisms with sporadic Alzheimer's disease. Biochem Biophys Res Commun, 1999; 265: 335-338
122. Stone DJ, Rozovsky I, Morgan TE et al: Astrocytes and microglia respond to estrogen with increased ApoE mRNA in vivo and in vitro. Exp Neurol, 1997; 143: 313-318
123. Aisen PS, Davis KL: Inflammatory mechanisms in Alzheimer disease: implications for therapy. Am J Psychiatry, 1994; 151: 1105-1013
124. Kurkowska-Jastrzȩbska I, Wrońska A, Kohutnicka M et al: The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridynine intoxication in mouse. Exp Neurol, 1999; 156: 50-61
125. McGeer PI., Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies. Neurology, 1996; 21: 195-218
126. Langub MC, Watson RE: Estrogen receptor - immunoreactive glia, endothelia and ependyma in guinea pig preoptic area and median eminence: electron microscopy. Endocrinology, 1992; 130: 364-372
127. Melcangi RC, Magnaghi V, Martini L: Steroid metabolism and effects in central and peripheral glial cells. J Neurobiol, 1999; 40: 471-483
128. Ganter S, Northoff H, Mannel D et al: Growth control of cultured microglia. J Neurosci Res, 1992; 33: 218-230
129. Dodel RC, Du Y, Bales KR et al: Sodium salicylate and 17beta estradiol attenuate nuclear transcription factor NF-κB translocation in cultured rat astroglia cultures following exposure to amyloid A beta (1-40) and lipopolysaccharide. J Neurochem, 1999; 73: 1453-1460
130. Drew PD, Chavis JA: Female sex steroids: effects upon microglial cell activation. J Neuroimmunol, 2000; 111: 77-85
131. Santizo RA., Anderson S, Ye S et al: Effects of estrogen on leukocyte adhesion after transient forebrain ischemia. Stroke, 2000; 31: 2231-2235
132. Garcia-Segura LM, Wozniak A, Azcoitia I et al: Aromatase expression by astrocytes after brain injury: implications for local estrogen formation in brain repair. Neuroscience, 1999; 89: 567-578
133. Eddelson M, Mucke L: Molecular profile of reactive astrocytes: implications for their role in neurologic disease. Neuroscience, 1993; 54: 15-36
134. Giulian D: Reactive glia as rivals in regulating neuronal survival. Glia, 1993; 7: 102-110
135. Miller WR, Mullen P: Factors influencing aromatase activity in the breast. J Steroid Biochem Molec Biol, 1903; 44: 597-604
136. Nestler JE: Regulation of aromatase activity of human placental cytotrophoblasts by insulin, insulin-like growth factor I and 11. J Steroid Biochem Molec Biol, 1993; 44: 449-457
137. Kritzer MF: Selective co-localization of immunoreactivity for intracellular gonadal hormone receptors and tyrosine hydroxylase in the ventral tegmental area, substantia nigra, and retrorubral fields in the rat. J Comp Neurol, 1997; 379: 247-260
138. Shughrue P, Scrimo P, Lane M et al: The distribution of estrogen receptor-beta mRNA in forebrain regions of the estrogen receptor-alpha knockout mouse. Endocrinology, 1997; 138: 5649-5652
139. Kuppers E, Beyer C: Expression of estrogen receptor-alpha and beta mRNA in the developing and adult mouse striatum. Neurosci Lett, 1999; 27: 95-98
140. Gundlah C, Kohama SG, Mirkes SJ et al: Distribution of estrogen receptor beta (ERbeta) mRNA in hypothalamus, midbrain and temporal lobe of spayed macaque: continued expression with hormone replacement. Brain Res Mol Brain Res, 2000; 76: 191-204
141. Di Paolo T, Bedard PJ, Dupont A et al: Effects of estradiol on intact and denervated striatal dopamine receptors and on dopamine levels: a biochemical and behavioral study. Can J Physiol Pharmacol, 1982; 60: 350-357
142. Gordon JH, Perry KO: Pre- and postsynaptic neurochemical alternation following estrogen-induced striatal dopamine hypo- and hypersensitivity. Brain Research Bull, 1983; 10: 425-428
143. Becker JB, Beer ME: The influence of estrogen on nigrostriatal dopamine activity: Behavioral and neurochemical evidence for both pre- and postsynaptic components. Behavioral Brain Reasearch, 1986; 19: 27-33
144. Pasqualini C, Olivier V, Guibert B et al: Acute stimulatory effect of estradiol on striatal dopamine synthesis. J Neurochem, 1995; 65: 1651-7
145. Bosse R, DiPaolo T: The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause. Cell Mol Neurobiol, 1996; 16: 199-212
146. Summer BE, Fink G: Testosterone as well as estrogen increases serotonin2A receptor mRNA and binding site densities in the male rat brain. Brain Res Mol Brain Res, 1998; 59: 205-214
147. Nicoletti F, Speciale C, Sortino MA et al: Estrogen effects on nigral glutamic acid decarboxylase activity: a possible role for catecholestrogen. Eur J Pharmacol, 1985; 115: 297-300